N,N'-bis-(Acid-PEG3)-benzothiazole Cy5
Code | Size | Price |
---|
TAR-T18453-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T18453-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N,N'-bis-(Acid-PEG3)-benzothiazole Cy5 is a polyethylene glycol (PEG)-derived PROTAC linker utilized in PROTAC synthesis[1].
CAS:
T18453
Molecular Weight:
777.39
Purity:
0.98
SMILES:
OC(CCOCCOCCOCC[N+]1=C(/C=C/C=C/C=C(N2CCOCCOCCOCCC(O)=C)\SC3=C2C=CC=C3)SC4=CC=CC=C41)=O.[Cl-]
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.